U.S. Markets closed

Days After a Shocking Cancer Failure, Incyte Goes Back to Work

Bloomberg
Days After a Shocking Cancer Failure, Incyte Goes Back to Work

Four days after Incyte Corp.'s once-promising cancer drug failed in the most anticipated clinical trial of the year, chemists in the firm's newly renovated labs were back at work, while other employees milled about the quiet headquarters, perched on a hill above Wilmington, Delaware. On the previous